While SELENOP expression was still lower in MSS cancers than in differentiated epithelial cells, we hypothesize that SELENOP upregulation throughout progression to malignancy fortifies tumor-promotive WNT signaling activity. The gene discussed is SELENOP; the disease is cancer.